FIELD: organometallic compounds, medicine, endocrinology. SUBSTANCE: invention relates to the development of novel biologically active nutritive supplements based on bis-(L-malato)-oxovanadium (IV) showing an insulin-like effect and exhibiting the prophylactic and therapeutic action in diabetes mellitus. EFFECT: expanded arsenal of nutritive supplements. 3 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION WITH ANTIDIABETIC EFFECT BASED ON OXOVANADIUM DERIVATIVE AND METHOD FOR IT PREPARING | 2001 |
|
RU2203656C1 |
OXOVANADIUM COMPLEXES OF L-MALIC ACID SHOWING HYPOGLYCEMIC ACTIVITY | 1996 |
|
RU2101287C1 |
AGENT THAT DISPLAYS ANTITUMOR ACTIVITY | 2008 |
|
RU2376020C1 |
OXOVANADIUM COMPLEX WITH GLYCINE MANIFESTING HYPOGLYCEMIC ACTIVITY | 2007 |
|
RU2341528C1 |
OXOVANADIUM (IV) COMPLEX IN DIMETHYL SULPHOXIDE POSSESSING ANTIDIABETIC ACTION AND METHOD FOR PRODUCING IT | 2014 |
|
RU2559894C1 |
ANTIDIABETIC AGENT "SAMSAR" | 1997 |
|
RU2114630C1 |
NOVEL CHELATE COMPOUND OF OXOVANADIUM (IV) WITH ISONICOTINIC ACID HYDRAZIDE SHOWING ANTIDIABETIC ACTION AND ELICITING ANTIMYCOBACTERIAL ACTIVITY | 1999 |
|
RU2190618C2 |
NOVEL VANADIUM DERIVATIVES HAVING HYPOGLYCEMIC ACTIVITY | 2019 |
|
RU2709491C1 |
AGENT FOR COMPLEX THERAPY OF CHRONIC DERMATOSIS, PSORIASIS, ATOPIC DERMATITIS, ECZEMA AND XERODERMIA AND METHOD OF TREATMENT OF CHRONIC DERMATOSIS | 2001 |
|
RU2196585C2 |
COMPOSITION EXHIBITING PROPERTY FOR BIOLOGICAL MEMBRANE REPAIRING | 1998 |
|
RU2133122C1 |
Authors
Dates
2002-10-20—Published
2000-03-13—Filed